Financials

News Discussions Technicals Forecast Seasonals

2186 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to LUYE PHARMA GROUP LIMITED operating, investing, and financing activities

2186 free cash flow for H1 24 is -892.82 M HKD. For 2023, 2186 free cash flow was 1.04 B HKD and operating cash flow was 1.74 B HKD.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: HKD

TTM

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—